Registered number= 01723353
Charity number: 326374
THE BRITISH BLOOD TRANSFUSION SOCIETY
(A company limited by guarantee
UNAUDITED
REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
CONTENTS
Page
Raf&ranc8 and administrative datsils of thg Society, its Council mombars and
advisors
Councll mem￿1$. r•port
Independent examiner's rnport
Statement of financial activities
Balan¢• sh$$t
10- 11
Notes to the financial statements
12-21

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE SOCIEfY. ITS COUNCIL MEMBERS AND
ADVISERS
FOR THE YEAR ENDED 31 MARCH 2026
Coun¢ll mombgrs
Dr D Roberts
Mrs C E George Iresigneil 7 October 20251
Dr I Sullivan {resigned 7 October 20251
Mr R C Hagga5, Treasurer
Miss J Staves, President
Mrs R Braund
Dr N Osaro (resigned 7 October 2025)
hAr D Gaskin
DTKIMead
Dr J Nash (appointed 7 October 20251
Miss S Wriqht lappointed 25 March 20261
Mr W Musabaike lappointed 21 Aprl 20261
Mr M Hazell lappoinled 7 May 20261
Company r•gl•t•r•d
number
01723353
Charlty rnglstsr•d
numbor
326374
Rogl•tsr•d offic•
CIO Amslrong Walson 1st Floor
One Slravbery Lane
Newcasle Upon Tyne
NE148X
BBTS Ex¢¢utiv•
Manager
David Noble
Accountants
Amistrong Watson LLP
Chartered Accountants
First Hoor
One Slrawbery Lane
Newcasle Upon Tyne
NE1 48X
Solicitors
Hay & Kilner LLP
The Lumen
Sl Jame5, Boulevard
New¢asOe Helix
Newcasue upon Tyne
NE4 5BZ
Page 1

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
COUNCIL MEMBERS. REPORT
FOR THE YEAR ENDED 31 MARCH 2026
The Counul members present their annual report together v*lh the finanual stslements of The British Blood
Transfusion Society for the year 1 April 2025 to 31 Mar¢h 2026. The ￿port serves the purposes of both a
Council members, report and a directors, report under company law.
The Council member5 confirm that the report and financial statements of the charitable company comply with
the current stslutory requirements, the requirements of the charitstrAe ¢ompany'5 goveming docufflenl and the
provisions of the Statement of Recommended Pra¢b'ce ISORPI applicable lo charities preparing their accounts
in accordance with the Financial Reporting Slandard applicable in the UK and Republic of Ireland IFRS1021
(effective 1 January 20191.
Structure. gov•rnan¢• and manag•m•nt
. Govornlng documont
The British Blood Transfusion Society was established in May 1983 as a company limited by guarantee
govemed by its Memorandum and Artides of Association (revised September 20111. It is registered as a charity
with the Charity Commission. Every member undertakes to contribute such an amount not exceeding £1, as
may be required in the event of the Society being wound up vA)le he is a member or within one year after they
cease to be a member.
Appolntment of Councll fflomb•r8
The Council members consist of officers. elected members and Pasl President or President Elect. Officers
consist of the President of the Society vtho holds office for years and the Secretary and Treasurer who hold
office for three years. The President can remain as a Council member for a further year after retirement from
the office of President. The Secretary and Treasurer are eligible for reappointment by Council, bul neither can
serve more than six consecutive years in office.
The elected Council members Shall be those members of the Councrf vtho a￿ not officers and shall each hold
office for a period of three years,. so far as possitle they shall be made up of a mix of professional categories
and be representative of the current membership.. Ihe period of office may be extended from lime to lime by the
President for a year with a maximum of three extensions providing a maximum term of Six years.
The Council members of the charitable company lexduding cwpted members) are rts directors for the
purposes of Company law and Iruslees lor the purposes of charity law. The elected Council members hold office
for a period of three years.
Calls for nominations for officers and elected members of Council are made in the BBTS Bloodlines New51etter
and also on the SorAety's website. Nominees musl be UK members and musl have been a member of the
Society for a minimum of two years. Nominations musl be proposed and seconded by two Society members.
Details of the nominees are then publisheo ¢)n the ballot papers.
¢. Induction and training of Council members
All new Counal members are given an induction pack containing informats'on, links and paperwork about the
roles and responsibilities of trustee5 published by the Charity Commission. They a150 receive pa51 Council
meeting papers and dales of forthcoming Council meeting5.
At the first meeting of the new Council. new members are introduced to individual Council members and
specific areas of responsibilty for new members are discussed and agreed. The Society's office then provides
all the necessary background inforniation and paper%￿)rk for new Council members, individual areas of
responsibility.
Page 2

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
COUNCIL MEMBERS. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
Structur•. gov•rnance and manag•m•nt lcontlnuodl
d. Organisation
The Society is managed by the Counul members. are responsiNe for the strategic direction and overview
of the work of the Society. The Counal members must number at least eight and not more than foLJrteen. all of
whom must be members of the Society. Three Councl members linduding at least one officer) are needed for
a quorum.
There are Committees and sulF¢ommrttees of Council members that may Cl￿p1 members who are not
members of the Council or Society. Cfropled members may not exceed thretyuarters of the lotsl number of
such committees. These Committees indude the Executive Wot*ing Committee, the Scientific Meetings
Administration Committee, the Communications Committee and the Professional Affairs & Education
Committee.
The day lo day operations of the chanty are managed by the BBTS Execvlive Manager and a small team of
stsff from an office based in Manchester.
•. BBTS Enterprf808 Llmlt•d
The ¢harity's ¥tholl*owned subsidiary was inwrporated in May 2003 and carries out trading aclivilie$ for the
charity. The subsidiary gift aids profits to the charity, Subject to the retention of reserves for 11$ own working
apital requirements.
f. Rl$k management
The members of the Council are responsible for overseeing the risks faced by the Society. Within thls process.
detailed consideration of risks is delegated lo the Executive Manager. Risks are identified. assessed and
conlrds established throughout the year. Risks a￿ held in a risk regisler. Council conducts ongoing reviews of
the major risks lo which the Society is exposed.
Page 3

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
COUNCIL MEMBERS. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
oblo¢￿v•S. actlvll•s and p•rfomian¢•
a. Obl•ctlve$ and a¢tlvbtbe$
The main aim of the Society is to athance for the pul￿1¢ benefft. the study of blood transfusion induding
immunohaemalology and lo promote research and development into all aspects of blood transfusion pracli¢e.
The objectives of the Society continue to be to=
Provide education and training, induding professitinal development
Provide a forum for discussion and communication and facilitate the exchange of ideas be￿en all
groups throu9h scientific meetings. special interest groups ISIGS) and the website
Foster links wth relevant national societies and organisations and ensure Society representation as
appropriate
Encourage research and development and disseminate information on new developments
Contribute lo the production of professional guidelines and promote best practice in all aspects of
Iranslusion medicine
Ensure recognits'on as the Profess￿nal body for Iransfvsion medicine by the govemment. health services
and the public
Contribute lo the advancement of knovAedge and services in developing countries
The Council gets itself annual objectives. in fvrtherance of the above main objectives of the Society. Each
objective has a performance measure and responsibility is allocated lo a Council member or Council sub-
committee. Performance against the annual objectives is ￿¥•evIe￿ al Counul meetings throughout the year
and a progress report put4i$hed in the Annual Review for members to view.
The Council confirm that they have been given the gerteral guidance produced by the Charity Commi55ion on
public benefit Including the guidance 'public benefit running a charity IPB21'. The Council are confident that
public benefit is acl)ieved through the study of blood transfusion and development.
Ik Achlovoments and perforniance
The Society's chartsble acts'vities focus on the sludy of transfusion and are undertaken to further ils
Charitable purpose$ for the public benefil as described in the followng paragraphs..
The Society ddivered its annual conference event in October 2025. The conference was held al
Harrogale HIC. The Soaety mel rts AGM obligations lo members on time.
The Society continued to protect its finances during the year and worked hard for members lo ensure it
an continue and expand on rts works and acts'vth'es in the years ahead.
The education programme5 conkn.nue lo provide valuable education and training opportunities and Sel out
tr8n5fusion best practice. 145 peoF4e look an examinatson with an overall 84% pa55 rale and 82 text books were
separately pur¢hase<l. Our VLE sollWa￿ contsnues lo evdve and be upgraded. The Mo¢xlle exam platfomi
sofvare, induding online marking, was upgraded and continues to perfomi well.
The CPD scheme provides a specific framework for transfijsion professionals. This year the Society had
480 members vtho were both registered and acb.ve on the scheme. CPD News conb.nues lo provide members
relevant opportunitses to learn and reflect. The Society continues to improve ils online CPD tool for members lo
populate and submit retums ele¢troni¢ally.
Through engagement with all members al every step the Society has continued to work closely with its
Equality, Diversity and Indusion Committee esta￿lShing fvrther updated Temis of Reference.
Page 4

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
COUNCIL MEMBERS. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
Oblo¢￿V*s. actlvll•s and p•rfomian¢• {¢ontinu•dl
Icontinuadl
Successfully delivering six edition5 of the Society's Transffijsion Medicine joumal and four edrf(ions of ils
membership magazine ￿(￿￿j1$￿eS.
The Society has continued its represenlations as a professional body working towards the delivery of safe
and effective transfusion practice.
During the year, Council achieved many of rts major objectives induding the improvement of our online course
delivery and online exams. maintaining a strong Transfusion Medicine impact factor and gaining a respectable
financial return from this joumal.
The Society continues to work hard to rewTite and add to its CTP course content, this project is now nearing
conclusion. We are planning to relaunch the course this year. We provided three educational webinars. We
created a PBM SIG for the first lime in the Society's history and created an Earfy Profes5iona15 Committee. We
continued lo miligale financial risk lo the Society during this penod and we now have no external funding which
means we are enlirdy financially IndependenL
Membership of the Society ha$ Changed during the year a$ follows..
Number ol members on l April 2025
Number ol new members
Number ol members who left
Number of members on 31 March 2026
1.487
141
12271
1,401
Flnanclal rnvlèw
a. Rosults
The principal funding sources of the Society are from training income and membership subscriptions. Income
from these sources is shown in note 5 to the financial Slalemenls.
The nel movement in fijnds for the year was a deficit of £74.38612025.' £40.1951, as shown in the statement of
financial activities. There was a gfft aid donation of £nil 12025.. £nill from the subsidiary thi5 year, so the
operational deficit was £74,386 {2025. £40.1951. The group deficit for the year was £86,46012025". £50,381).
Ik Rosorves policy
Council has established a policy whereby the unrestricted funds not committed. designated or invested in
tangible fixed assets (the free reserves) held by the group should equate to at least £400.000. The reserves are
needed to meet the ongoing working capital requirements of the group, to bridge any funding gaps during the
development of new activ￿eS and lo enable the group lo continue its current activities in the event of a
5ignrficant drop in income.
The free reserves of the charty as at 31 March 2026 were £330,082 {2025.' £404,468) and those of the trading
subsidiary add a further £66,721 12025 £78,795), a total of £396.80312025'. £483,263).
Page 5

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
COUNCIL MEMBERS. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
¢. Inv•stmont po￿1$ and policy
Under the Memorandum and Articles of Association, the Society has the power lo make investments as the
Council members see fil.
Having regard lo the Society's liquidity requirements and reserves policy. Council have, in recent years,
operated a pdicy of keeping available funds in interest-bearing deposit accounts.
d. Golng concorn
After making appropriate enquiries, the Council members have a reasonable expectation that the Society has
adequate resources lo continue in operational existence for the foreseeable future. For this rea50n, they
continue lo adopt the going concem basis in prepanng the financial slatemenls. Further detsils regarding the
adoption of the going concern basis can be found in the accounting pdiues.
Plans for future periods
The Council has set rtself a number of annual objeclives for 2026127. in ftjrtherance of the main objectives of
the Society. These objectives indude the followng".
building on the strategies for membership expansion..
conclude the Written update of ils Transfusion Science Practice COUTsebook',
relaunch of ils Clinical Transfusion Practice course.,
lo continue the successftjl delivery of online webinars",
conts'nually enhance our online exams to improve delivery and marking..
bring our SiGs and their goals doser lo the day to day work ol Council..
conlinue to r&enforce our rdationships wih oiher professional bodies,.
launch a new membership grade for lower band transfusion woikers,.
launch an Earfy Career Professionals membership grade..
launch a BBTS mentorship scheme".
continue lo ensure ils finances a￿ adequate fdloV￿n9 wthdrawal of fvnding."
review alternative conference venues to protecl our finan¢e$ and reserve$
Page 6

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
COUNCIL MEMBERS. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
Statsm•nt of Councll m•mb•rn' rnsponsibllltlos
The Council members (who are also the directors of the Society for the purposes of company lawl are
responsible for preparing the Council members. report including the Strategic report and the financial
stslements in accordance wlh applicable law and Untied Kingdom Accounb"ng Stsndards (United Kingdom
Generally Accepted Accounbng Pra¢ti¢el.
Company law requires the Council members to prepare financial slalements for each financial year. Under
company law. the Council members musl not approve the financial stslements unless they a￿ satisfied that
they give a Inje and fair view of the slate of affairs of the Society and ol ils in¢oming resources and application
of resources, including its income and expenditure, for that period. In preparing these financial statements, the
Council members are required to..
seled sulta￿e accounting poliues and then ap￿Y them ￿nsIsten0Y.,
observe the method5 and princiF4es of the Charities SORP IFRS 1021.,
make judgments and accountsng esbmales that are reasonable and prudent..
slate whether applicable UK Accounting Standards IFRS 1021 have been followed, subject to any
material departures disdosed and explained in the financial slalemenls.,
prepare the financial statements on the going concern basis unless il is inappropriate lo presume that the
Society will continue in business.
The Council members are responsitAe for keeping adequate accounting records that are sufficient lo show and
explain the Society's transactions and di$dose wth reasonable a￿￿Ta¢Y at any lime the financial position of the
Society and enable them to ensure thal the financial slatements comply wih the Companies Act 2006. They are
also responsible for safeguarding the assets of the Society and hence for taking reasonable steps for the
prevention and detection ol fraud and other irregularities.
Approved by order of the members of the board of C¢)uncil members and signed on their behalf by..
Mlss J Staves
(Chair of Tru5teesl
Dale..
1110912026
Page 7

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
INDEPENDENT EXAMINER'S REPORT
FOR THE YEAR ENDED 31 MARCH 2026
Independent examiner's report to the Coun¢il mèmbets of The British Blood Trnnsfusion
Soci&ty I'the So¢igty'1
I report lo the chanty Council member5 on my examination of the accounts of the Society for the year ended 31
March 2026.
Responsibilities and basis of report
As the Council members of the So¢iety land ils directors foc the purposes of company lawl you are responsible
for the preparation of the a￿￿￿ts in ac￿rdanCe Ihe requirement$ of the Companie$ Act 20061'lhe 2006
Act'l.
Having satisfied mysdf that the accounts of the Society are not required to be audited under Part 16 of the 2006
Act and are eligible for independent examination, I report in respect of my examination of the Society's accounts
carried out under section 145 of the Charities Act 2011 {Ihe 2011 Act'l. In carrying out my examination I have
followed the Directions given by the Charity Commission under section 1451Sllbl of the 2011 Act.
Independent examln•r'$ ststemont
Since the Society's gross income exceeded £250,000 your examiner musl be a member of 8 body listed in
section 14S of the 2011 Act. I confirm that l am qualified to undertake the examinats'on because l am a member
of ACA, which is one of the listed bodies.
I have com￿eted my examination. I confim that no matters have come lo my attention in connection the
examin*ion giving me cause lo believe..
accounting records were not kept in respect of the Swety as required by section 386 of the 2006 Act,. or
the accounts do not accord wth those records." or
the accounts fjo not ¢omF4y wrth the accounting ￿qUIrementS ol section 396 of the 2006 Act other than
any requirement that the accounts give a 'true and fairf view which 1$ not a matter ¢onsidered as part of
an independent examinats'on., or
the accounts have not been prepared In accordance wth the methods and principle5 of the Slalemenl of
Recommended Practice for accounting and reporting by charities lappli¢aUe lo charities preparing their
accounts in accordance wrth the Financial Repo￿"n9 Stsndard applicable in the UK and Republic of
Ireland IFRS 10211.
I have no concerns and have come across no other matters in o)nnecb'on wlh the examination lo which
attention should be drawn in this report in order lo enat* a proper understanding of the accounts lo be
reached.
This report is made solely lo the So¢ieVs Cound members. as a body. in accordance ￿th Part 4 of the
Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the
Society's Council members those matters l am required to state to them in an Independent examinerfs report
and for no other purpose. To the fullest extent pemitted by law, I do not accept or assume responsibility to
anyone other than the Society and the Socielys Council members as a body, for my work or for this report.
Dated..
1110912026
E Chapthwé*pman (Ocl
Amistrong Watson LLP
One Strawberry Lane
Newcastle upon Tyne
NE1 4BX
0 2026 10 49.'33 GMT) Independent Examiner
Page 8

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNTI
FOR THE YEAR ENDED 31 MARCH 2026
Unr•strl¢tsd
funds
2026
Totsl
funds
2026
Total
funds
2025
Income from:
Donations
1,528
11,084
268.437
1,S28
11,084
268,437
14,215
74,099
267,852
Investments
Charitable acliwtses
Total incom8
281.049
281,049
290, 166
Expondlture on:
CharIta￿e acliwbes
355.435
355,435
330,361
Total oxpondltur¢
3SS.435
355,435
330,361
Not l•xpendlturo1 Incom• and movom•nt In lund•
174,386)
174,3861
(40. 195)
Ro¢on¢lllatlon of funds:
Total funds brought forward
Net movement in funds
404,468
174.386)
404,468
174,3861
444,663
(40, 195)
Total funds carrl•d forKdrd
330,082
330,082
404,468
The Statement of financial activities inclLths all gains and losses recognised in the year.
The notes on pages 12 to 21 form part ol these financial statements.
Page 9

THE BRITISH BLOOD TRANSFUSION SOCIETY
IA Company limitsd by guarantetrl
REGISTERED NUMBER: 01723353
BALAMCE SHEET
AS AT 31 MARCH 2026
2026
2025
Mole
Fixed assets
Intangible assets
Tangible assets
Inve51ment5
10
38,499
3,082
44,956
2,857
12
41,582
47,814
Current assets
Debtors
Cash al bank and in hand
13
177,358
282,957
783.893
312,469
460,315
496,362
Current Ilabllltl•s
Creditors.. amounts falling due wlhin one
year
14
1166,7491
(133,376)
Not currnnt a##èt*
293,566
362.986
Totsl ass•ts1g$$ ¢urrnnt1Sabilltles
33S,148
410,800
Capital grant
15,0661
(6,3321
Net assets
330,082
404.468
Total net assots
330,082
404,468
Page 10

THE BRITISH BLOOD TRANSFUSION SOCIETY
IA Company limitsd by guarantetrl
REGISTERED NUMBER: 01723353
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2026
2026
2025
Mole
Charity funds
Reslricled lunds
Unre$tri¢ted fund$
15
15
330,082
404,468
Total funds
330,082
404.468
The Society was entitled lo exempb.on from audit under section 477 of the Companies Act 2006.
The members have not required the company lo obtain an audr( for the year in question in accordance wth
section 478 of Companies Ad 2006.
The Council members acknovAedge their responsibilrties for complying wth the requiremen15 of the Act with
respect lo accounting re￿rdS and preparatson of finanual slatemenls.
The financial slalemenls have been prepared in accordance the provisions applicable lo enlilies subject lo
the Small ¢gmpanie$ regime.
The financial statements were approved and aulhorised for issue by the Council members and gigned on their
behalf by..
Mig9 J Stsves
(Chair of Trusleesl
Dale.,
1110912026
The notes on pages 12 to 21 form part of these financial stalements.
Page 11

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
General infomiation
The Society Is a company limited by guarantee and has no share capital. The liability of each member in
the event of wnding up is limited to £1.
Accounting poll¢l•s
2.1 8asis of preparation of financial statements
The financial statements have been prepared in ae¢ordanee wlh the Charities SORP IFRS 1021
Accounting and Reporting by Chanties." Slalement of Recommended Practice applicable to charities
preparing their accounts in accordance ￿th the Financial Repo￿.ng Stsndard applicable in the UK
and Republic of Ireland IFRS 1021 leffectsve 1 January 20191, the Financial Reporting Standard
applicable in the UK and Republic of Ireland IFRS 1021 and the Companies Act 2006.
The financial statements are ￿pared in Sterling %thi¢h 1$ the fun¢b"onal and presenlab'on currency of
the charity.
The British Blood Transfvsion Society meets the definition of a public benefit entity under FRS 102,
Assets and liabilities are initially reco9niged at historical eosl or Iran$4ction valuè unlegy otherwisè
staled in the relevant accountsng policy.
2.2 Income
All income is induded in the statement of financial ath'vities when the charity is entided to the
income and the amount can be quantified with reasonable accuracy. The following specrfic
policies are applied to particular categories of income..
Ck>nations are received by vray of grants and donations and are included in fvll in the Stslement of
financial activities on a re¢eivat4e basis. The balan¢e of income received for spe¢ifi¢ purposes bul
not expended during the period is shown in the relevant fvnds on the Balance sheet. Where income
is received in advance of entitlement of receipt, its recognition is deferred and included in creditors
as deferred income. Vvhere enlrtlement occurs before income is received, thè income is accrued.
Income from charitable acts'vibes includes income from membership subscriptions and training and is
recognised in the period in which the Society is entiljed to receipt. Deferred income represents
amounts received for future periods and is released to the statement of finanaal activities for the
period for which rt has been released.
2.3 Exptrnditur•
Expenditure is recognised once there is a legal or constructive obligation to transfer economic
benefit to a third paty, rt is probat4e that a transfer of economic benefits will be required in
se￿ement and the amount of the obligation can be measured reliably.
Expenditure is dassified by acb"vty. The costs of each actiwty a￿ made up of the total of direct costs
and shared co$ls. induding support costs invrAved in undertaking each activity.
Direct costs attributat4e lo a single activty are allocated direcdy to that activty. Shared costs which
contribute lo more than one activity and support costs ￿lch are not attributable lo a single activity
are apportioned between those activrb.es on a basi5 con51slent wth the use of resour¢e5.
Expenditure on ¢harit3Ne activities is incurred on directly undertakn'ng Ihe a¢tivrties which ftjrther the
Society's objectives, as well as any associated support costs.
Page 12

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
Accounting poli¢io5 Icontinu•d}
2.3 Expenditure (continued)
All expenditure is indusive of irrecoverable VAT.
2.4 Internst r8c•ivable
Interest on funds held on deposit is included when receivatle and the amount can be measured
reliably by the Souety", this is normally upon nolificatson of the interest paid or payable by the
institution wth whom the funds are deposrted.
2.5 Intsngible assets and amortisation
Intangible assets are inrtially recognised at cosL After recognition, under the cost model, intangible
assets are measured al cost less any acCuM￿ated amorts"salion and any accumulated impairment
losses.
Amortisation is provided on intangible assets at rates caculaled lo write off the cost of each asset on
a straight-line basis over its expected useful life.
The eslimaled useful lives are as follows..
Website costs
S years
2.6 Tanglblo flx•d a880ts and d•pr8clatSon
Tangit4e fixed assets are induded in the finanual Stslemenls al their historical cost.
Depreciation is charged so as to allocate the cost of tangible fixed assets less their ￿SIdUal value
over Iheir eslimaled uselul lives.
Depreciation is provided on the following basis..
Fixtu￿$ and fittings
Computer equipment
20% On straight line basis
25% On slraight line basis
2.7 Investments
The investment in the subsidiary undertaking is induded in the financial 51atemenls al cost. The
financial slalemenls for the Society indude only the indwidual parent charty and are not
consolidated lo indude the trading subsidiary. The pa￿nI Charity is not required lo prepare
consolidated financial statements under section 399 of the Companies Act 2006 and is excepted by
section 139121 of the Chariiies Act 2011 from the requirement to prepare group accounts.
2.8 Debtors
Trade and other debtors are re¢ognised * the setdement amount after any trade discount offered.
Prepayments are valued at the amount prepaKI net of any trade discounts due.
2.9 C•sh at bank and in hand
Cash at bank indudes a current account and an instsnt access COIF Charities Deposit Fund
account
Page 13

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
Accounting poli¢io5 Icontinu•d}
2.10 Liabilities
Liabilities and provisions are recognised when there is an olAigalion at the Balance sheet dale as a
result of a past event. rt is probable that a transfer of economic benefit will be required in setdement.
and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the Society anlicipates il will pay lo settle the debt or the
amount il has received as advanced payments for the goods or service5 11 mu51 provide.
2.11 Flnanclal Instruments
The Society only has financial assets and financial liablities of a kind that qualify as basic financial
instruments. Basic financial instruments are initially recognised at transaction value and
subsequendy measured at their settlement V￿ue.
2.12 Fund Structure
General funds are unrestricted funds vthich are availaL4e for use at the discretion of the Council
members in furtherance of the gener￿ objectives of the Society and which have not been
designated for other purposes. The general fund is credited wth subs¢riplion$ received from
members and income from Iraining ￿Urse$ and associated income.11 is charged with the charitable
expendrture anil governance cosls of the Society.
Designated funds comprise unresiricted funds that have been sel aside by the Council members for
particular purposes. The aim and use of any designated fund is set out in the notes to the financial
slalemenls.
Grants obtained for specffic PU￿Se$ a￿ recognised in the financial stslemenls as ￿$triCted funds.
Investment income, gains and losses are allocated to the appropriate fund.
2.13 Judgemonts and key Sources of estimation uncèrtainty
In apk￿￿ng the Societys accounting policies. the Council members are required lo make
judgements. estimates and assumptions in delemining the carrying amounts of assets and
liabilities. The Coun￿1 members. judgements, estimates and assumptions are based on the best
and most reliable evidence available at the time when the decisions are made, and are based on
historical experience and other factors that are considered lo be applicable.
Due lo the inherent subjeclivty involved in making such judgements. estimates and assumptions.
the actual results and outcomes may drffer. The estimates and undetlying assumptions are reviewed
on an ongoing basis. Revisions lo accounting estimates are recognised in the period in which the
estimate is revised, if the rewsion affects onty thal penod, or in the period of the revision and future
periods. if the revision affects both current and future periods
Page 14

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
Income from donations
Unrnstrictsd Ro$trictsd
funds
funds
2026
2026
Total
funds
2026
Donations
Grants
262
1,266
262
1,266
1.528
1.528
Unrnslncled
funds
2025
R8slncled
funds
2025
Total
funds
2025
Don8li¢ns
Grants
215
215
14,000
14,000
215
14,000
14,275
Invo•tmont Income
Unrestrlcted
funds
2026
Total
funds
2026
Total
funds
2025
Bank interest
11,084
11,084
14,099
Charitable activities
Unrostrlctsd
funds
2026
Total
funds
2026
Total
funds
2025
Membership subscriptsons
Training
115,388
153,049
11S,388
153,049
919,621
142,231
268.437
268,437
261,852
Page 15

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
Independent examiner's remuneration
2026
2025
Fees payable to the Societys indeperKlent examiner for the independent
examination of the Socaety's annual accounts
Fees payable lo the Soi?eWs independent examiner in respecl ot.
All other services not induded above
1.640
1,320
9,143
8,418
Total rnsources eX￿nd•d
Charftsb
Govemanco
Total
Tol81
actlvltles
costs
2026
2025
Direct costs
Publicity and publicatsons
Educational programme
Modernisino Scientific Careers
2,862
119,622
24,749
2.862
2,722
119,622 110,974
24,749 24,121
Allocated support costs
Staff costs
Office costs
Depreciation and amortisalion
Accountancy lee$
Legal and other professional fees
110,061
40.070
7,484
5,007
539
19,423 129,484 117,546
17.173
57,243 63,868
3,208
10,692
867
5,006
10,013
9,002
231
770
1,267
Stsff ¢osts and nUm￿r$
2026
2025
Waoes and salaries
National insurance costs
Pension costs
17S,579
12,890
762,765
8, 149
198 426
782 639
Average number of employees in the year
(all management and adminislralivel
Page 16

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
Council members. remuneration and expenses
During the year, no Councl members received any remuneration or other benefits (2025- £NIL).
During the year ended 31 March 2026, expenses totalling £457 were reimbursed or paid diredy to 4
Council members (2025- £2.386 to 6 Counul membersj.
10. Intsnglble a$s•ts
Wobslts
Cost
Al 1 April 2025
Additions
44,9S6
3.168
Al 31 March 2026
48.124
Amortl8atlon
Charge for the year
9.625
Al 31 March 2026
9.625
Not book value
Al 31 March 2026
38.499
Al 37 Ma￿￿ 2025
44,956
Page 17

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
11. Tangible fixed assets
Fixturns and
fittings
Computar
oquipmont
Totsl
Cost or valuatlon
At 1 April 2025
Additions
9,122
9,598
1.293
18,718
1,293
Al 31 March 2026
9.122
10,889
20,011
D•preclatlon
Al 1 April 2025
Charge for the year
9,122
6,739
1,068
15,861
1,068
Al 31 March 2026
9.122
7,807
16,929
Not book value
Al 31 March 2026
3,082
3,082
Al 31 Ma￿￿ 2025
2,857
2,857
12. Flx•d assot Inv•stm•nts
Investments
In
subsldlary
companios
Cost or valuatlon
At 1 April 2025
Al 31 March 2026
Ngl book value
At 31 March 2026
Al 31 Ma￿h 2025
Page 18

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
13. Debtors
2026
2025
Due viithin one year
Trade debtors
Amounts due from subsidiary undertakings
Prepayments and accrued income
14.252
132,588
30.518
10.702
f 44,613
28,578
177,358
783.893
1& Credllors: Amounts falling du• vAthin ong yoar
2026
2025
Trade crgtjitors
Other taxation and social security
Other creditors
Accruals and defer￿d income
27,041
14.285
715
124,708
10,304
5,846
6, 787
110.445
166,749
133,376
2026
2025
Deferred income al l April 2025
Resources deferred during the year
Amounts released from previous periods
100,075
91,906
1100.075}
104.263
100,075
(704,2631
91,906
100.075
Page 19

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
1& Statement of funds
Statom•nt of lund$- Current year
Balanc8 at
31 March
2026
Balance at 1
April 2025
Income Expenditure
Unrestrictèd funds
404.468
279.783
{354.1691
330,082
Gener￿ funds
16. Analys1$ of n•t a$￿ts bOt￿n lund•
Analysis of not a$$gts bgt¥wen funds- ¢urrnnt yo•r
UnrnBtrlcted
fund6
2026
Total
lunds
2026
Tangible fixed assets
Intangible fixed assets
Fixed asset investments
Current assets
Creditors due wthin one year
Capital grant
3,082
38,499
3,082
38.499
460,315
1168,7491
15,0661
460,315
1166,7491
15.0661
Total
330,082
330,082
Analysis of not assets bet￿￿n funds. prior year
un￿$t17cl8d
funds
2025
Total
funds
2025
Tangible fixed assets
Intangible fixed assets
Fixed asset investments
Current a5set5
Creditors due wrthin one year
Capital grant
2,85T
44,956
2,857
44,956
496,362
(133.376)
(6,332)
496,362
(133.316)
(6,332)
Total
404.468
404.468
Page 20

THE BRITISH BLOOD TRANSFUSION SOCIETY
(A ¢ompany limitsd by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
17.
Principal subsidiaries
The following We￿ subsidiary undertakings of the Society-
Namos
Company
number
Principal plac8 Class of Holding
of business
shares
BBTS Enterprises Limited
4775642
England
Ordinary
100%
The finan¢ial results of the subsidiary for the year were..
Name
Incom•
Expenditure
Deficit for
the year
BBTS Enterprises Limited
42S.846
437,920
112,0741
Not as80ts
76,721
Page 21